Verified against court and regulatory records · No upfront fees · Your information is never sold
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Free · Confidential · About 2 minutes · A case specialist responds within 1 business day
Your answers are never sold or shared without your consent.
The Verdict Landscape: State Court and Federal MDL Results
NEC formula litigation has produced extraordinary jury verdicts — reflecting the profound outrage of juries confronted with evidence that large pharmaceutical corporations marketed products they knew or should have known were dangerous to the most vulnerable patients in medicine: premature infants in the NICU. The verdicts are divided between state court cases (primarily in Missouri, Illinois, and Texas) and federal bellwether trials within MDL 3026 in the Northern District of Illinois. State court verdicts preceded the MDL and were among the first public signals that NEC litigation could produce massive recoveries. The largest single verdict — $495 million against Mead Johnson in Missouri in 2022 — included $490 million in punitive damages and sent a clear signal to both defendants about the trial risk they face. Federal MDL bellwether verdicts, including the $65 million verdict against Abbott in July 2024, have validated the plaintiffs' evidence and litigation theory in the federal forum.
How Verdicts Influence Settlements Across the MDL
The bellwether trial program in MDL 3026 is specifically designed to produce verdicts that inform global settlement negotiations. When a bellwether jury awards $65 million, that result communicates to Abbott's legal team that their product and their conduct are viewed by ordinary citizens as worthy of significant condemnation. It also demonstrates that the plaintiffs' scientific and medical experts are credible and persuasive to juries. This trial risk assessment drives the settlement value that Abbott and Mead Johnson's counsel are authorized to offer in resolution of the broader case inventory. As more bellwether results accumulate — particularly if they consistently favor plaintiffs — the pressure on the defendants to reach a global settlement increases. Families whose cases are in the MDL benefit from this process even if their individual case never goes to trial.
Settlement vs. Trial: What Families Should Know
The vast majority of NEC formula cases will ultimately resolve through settlement — either individual settlements negotiated by your attorney with the defendant's counsel, or as part of a global resolution of some or all of the MDL cases. A global settlement — sometimes called a mass settlement or omnibus settlement — involves the defendant agreeing to pay a lump sum to be distributed among all eligible claimants according to a point system or allocation formula that values cases based on factors like severity of injury, extent of formula exposure, and jurisdiction. Individual settlements are negotiated case-by-case and may produce higher or lower values depending on the specific facts. Your attorney will advise you on the merits of any settlement offer and whether trial would produce a better outcome for your specific case. Settlement offers release all claims against the defendant, so the decision to accept requires careful consideration.
Key data
Data & Statistics
$495 million
St. Louis County Circuit Court
$65 million
MDL 3026, N.D. Illinois
FAQ
Frequently Asked Questions
Dive deeper
Related Guides
- NEC Disease Overview: Stages, Symptoms, and What Happens in the NICUNecrotizing Enterocolitis is a staged disease. Early detection (Stage I) allows medical management; advanced NEC (Stage III) requires emergency bowel surgery with a mortality rate of 20-30%. Understanding the stages, warning signs, and typical NICU progression is essential for families trying to understand what happened to their baby and whether they have a legal claim.
- NEC Evidence and Records: What to Gather and Why It MattersBuilding a successful NEC formula case requires three categories of records: (1) NICU feeding logs documenting formula product and volume; (2) diagnostic records confirming the NEC diagnosis; and (3) long-term medical records documenting the lasting harm. You do not need these records before contacting an attorney — your attorney can obtain them for you — but understanding what is needed helps families gather and preserve evidence.
- NEC Statute of Limitations: State-by-State Deadlines and Minor Tolling RulesThe statute of limitations for NEC formula cases is among the most nuanced in all of mass tort law. Most states toll the SOL for personal injury claims belonging to minor children until the child turns 18 — meaning surviving NEC children often have claims that will not expire for many years. Parents filing their own claims (wrongful death or loss of consortium) face shorter deadlines. Do not assume your claim is time-barred without consulting a NEC attorney.
- Similac NEC Lawsuit: Abbott Laboratories and Similac Special Care FormulaAbbott Laboratories manufactures Similac Special Care — the most widely used cow's milk-based premature infant formula in the United States. Abbott has faced thousands of NEC lawsuits across state and federal courts, with bellwether verdicts in MDL 3026 producing nine-figure jury awards. Families whose premature infants developed NEC after receiving Similac in the NICU may have viable product liability claims against Abbott.
- Enfamil NEC Lawsuit: Mead Johnson/Reckitt and Enfamil Premature FormulaMead Johnson Nutrition — now owned by the British consumer goods giant Reckitt — manufactures Enfamil Premature, a cow's milk-based premature infant formula widely used in NICUs. Mead Johnson has faced some of the largest NEC jury verdicts in history, including a $495 million verdict in Missouri and a $60 million verdict in Illinois. Families whose premature infants received Enfamil in the NICU should contact a NEC attorney immediately.
- Why Premature Infants Are Uniquely Vulnerable to NECThe extreme vulnerability of premature infants to NEC is not an unfortunate coincidence — it is a biological certainty rooted in the profound immaturity of the preterm gut. Understanding why preterm infants are uniquely at risk helps families understand both the medical reality of what happened to their baby and why the NEC risk associated with cow's milk formula should have been disclosed more clearly.
- Breast Milk vs. Formula and NEC: AAP Guidelines and the Donor Milk AlternativeThe American Academy of Pediatrics, the World Health Organization, and the Human Milk Banking Association of North America all recommend pasteurized donor breast milk — not cow's milk-based formula — as the preferred alternative when a mother's own milk is unavailable for premature infants. The failure of Abbott and Mead Johnson to acknowledge this guidance in their marketing to NICUs is central to the NEC litigation.
- NEC MDL 3026 in the Northern District of Illinois: What Families Need to KnowMDL No. 3026 — In Re: Abbott Laboratories, et al., Preterm Infant Formula Products Liability Litigation — is pending before Chief Judge Rebecca R. Pallmeyer in the United States District Court for the Northern District of Illinois. Understanding how the MDL works, what the bellwether trial program has produced, and how your individual case fits into the larger litigation is essential for families considering filing a NEC formula claim.
- NEC Wrongful Death Claims: When a Premature Baby Does Not SurviveLosing a premature baby to NEC is an unimaginable tragedy. Families who lost their infants after NEC developed following formula feeding in the NICU may have wrongful death claims against Abbott and Mead Johnson. These cases carry some of the highest verdicts in the NEC litigation — including nine-figure jury awards — because juries respond powerfully to the preventable death of a premature baby.
- NEC Long-Term Disabilities: Short Bowel Syndrome, TPN, and Neurodevelopmental HarmSurviving NEC is only the beginning of a long medical journey for many premature infants. Short Bowel Syndrome, TPN dependency, intestinal failure-associated liver disease, and neurodevelopmental disabilities including cerebral palsy and cognitive impairment are common long-term sequelae of NEC. These lifelong medical needs dramatically increase the damages available in surviving-infant NEC claims.
- NEC Hospital Liability: Can the NICU or Hospital Also Be Held Responsible?In addition to product liability claims against Abbott and Mead Johnson, some NEC families may have medical malpractice claims against the hospital or NICU if the medical team deviated from the standard of care by failing to follow evidence-based breast milk guidelines, failing to inform parents of the NEC risk of formula, or failing to timely diagnose and treat NEC once it developed.
The full investigation